tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate
- CAS No.
- 365998-36-3
- Chemical Name:
- tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate
- Synonyms
- CarbaMic acid, N-[(1R,2S,5S)-2-aMino-5-[(diMethylaMino)carbonyl]cyclohexyl]-, 1,1-diMethylethyl ester;Edoxaban INTERMEDIATES Ⅰ;tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate;(1S,2R,4S)-N2-(tert-butoxycarbonyl)-4-(N,N-dimethylcarbamoyl)-1,2-cyclohexanediamine;D-1315;(5H-Pyrrolo[3;Edoxaban Impurity 47;Paracetamol Impurity 27;InterMediate of Edoxaban;Edoxaban INTERMEDIATES Ⅲ
- CBNumber:
- CB02652836
- Molecular Formula:
- C14H27N3O3
- Molecular Weight:
- 285.38
- MDL Number:
- MFCD22190570
- MOL File:
- 365998-36-3.mol
- MSDS File:
- SDS
| Boiling point | 434.4±45.0 °C(Predicted) |
|---|---|
| Density | 1.09±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C(protect from light) |
| form | Solid |
| pka | 11.90±0.60(Predicted) |
| Appearance | White to off-white Solid |
| optical activity | -38.5°(C=0.01g/mL, MEOH, 20°C, 589nm) |
| InChI | InChI=1S/C14H27N3O3/c1-14(2,3)20-13(19)16-11-8-9(6-7-10(11)15)12(18)17(4)5/h9-11H,6-8,15H2,1-5H3,(H,16,19)/t9-,10-,11+/m0/s1 |
| InChIKey | JCHIBKSSZNWERE-GARJFASQSA-N |
| SMILES | C(OC(C)(C)C)(=O)N[C@@H]1C[C@@H](C(N(C)C)=O)CC[C@@H]1N |
| CAS DataBase Reference | 365998-36-3 |
| Comptox DTXSID | DTXSID40677331 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501 |
tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate price More Price(23)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Synthonix | B23313 | tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate 97.0% | 365998-36-3 | 1g | $25 | 2026-05-06 | Buy |
| Synthonix | B23313 | tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate 97.0% | 365998-36-3 | 5g | $50 | 2026-05-06 | Buy |
| Synthonix | B23313 | tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate 97.0% | 365998-36-3 | 10g | $90 | 2026-05-06 | Buy |
| aablocks | AA00CKN4 | tert-Butyl ((1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate 95% | 365998-36-3 | 1g | $12 | 2026-05-28 | Buy |
| aablocks | AA00CKN4 | tert-Butyl ((1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate 95% | 365998-36-3 | 5g | $34 | 2026-05-28 | Buy |
tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate Chemical Properties, Uses, Production
Description
Tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate is a pharmaceutical intermediate compound used in the preparation of Edoxaban. Edoxaban is an oral anticoagulant drug used for the treatment of strokes due to blood clots, thrombosis, heart disease and cirrhosis of the liver.
Uses
Tert-butyl(1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate is an organic synthesis intermediates and pharmaceutical intermediates, which can be used in laboratory research and development processes and chemical and pharmaceutical synthesis processes. It is a reagent used in the synthesis of cis-1,2-diaminocyclohexane derivative. It is also mainly used as raw material to synthesize reversible factor Xa inhibitor drug edoxaban[1]. The drug has been approved by the U.S. Food and Drug Administration as a direct oral anticoagulant and is the fourth direct oral anticoagulant approved for clinical use[2-3].
Referance:[1] Frantisek Nehaj, Juraj Sokol, Jela Ivankova, Michal Mokan, Marian Mokan, Jan Stasko, Edoxaban affects TRAP-dependent platelet aggregation, Journal of Thrombosis and Thrombolysis, 2020, 49, 578-583.
[2] Juraj Sokol, Frantisek Nehaj, Jela Ivankova, Michal Mokan, Lenka Lisa, Jana Zolkova, Lubica Vadelova, Marian Mokan, Jan Stasko, Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation,Clinical and Applied Thrombosis/Hemostasis, 2020.
[3] Mara Poulakos, Jacqueline N Walker, Umima Baig, Tosin David, Edoxaban: A direct oral anticoagulant, American Journal of Health-System Pharmacy, 2017,74, 117–129.


tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate Preparation Products And Raw materials
Raw materials
1of2
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Jiangsu Vcare PharmaTech Co., Ltd. | 025-58741518 13327700685 | sales@vcarepharmatech.com | China | 281 | 61 |
| Jinan Lide Pharmaceutical Technology Co., Ltd. | 0531-68654990 18560195202 | leadgxm@leadchem.net | China | 198 | 58 |
| ZHUHAI HRD PHARMACEUTICAL CO., LTD. | 7737188 13326687259 | sales@hrdpharm.com | China | 141 | 58 |
| Beijing Chempion Pharm-Tech Co. Ltd. | 17302533743 | BD@chempion.com.cn | China | 121 | 58 |
| Shandong Shengzhiyuan Biotechnology Co., LTD | 13969162569 | szyyy01@163.com | China | 184 | 58 |
| CANGZHOU SENARY CHEMICAL S&T CO.,LTD | 18698023886 | qiaojingwen@desano.com | China | 19 | 58 |
| Shandong Jincheng Pharmaceutical Group Co.,Ltd. | 0533-5439427 13964385406; | henry.zhang@jinchengpharm.com | China | 44 | 58 |
| shanghai yayu biomedical co.,ltd | 021-54370211 18051886391 | 3007215920@qq.com | China | 2985 | 58 |
| Enantiotech Corporation Ltd | 760-85282375 15900088539 | sale02@enantiotech.com | China | 84 | 55 |
| Adamas Reagent, Ltd. | 4006009262 13023226327 | hmj@titansci.com | China | 14097 | 59 |
View Latest Price from tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-11-20 | (5H-Pyrrolo[3,4-d]thiazole-5-carboxylic acid,2-[[[(1R,2S,5S)-2-[[(5-chloro-1H-indol-2-yl)carbonyl]aMino]-5-[(diMethylaMino)carbonyl]cyclohexyl]aMino]carbonyl]-4,6-dihydro-,1,1-diMethylethyl ester
365998-36-3
|
0.99 | RongNa Biotechnology Co.,Ltd | ||||
![]() |
2026-05-22 | tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate
365998-36-3
|
99.99% | 200000T | Anhuyan (Hainan) Biotechnology Co., LTD | |||
![]() |
2026-04-09 | Tert-Butyl ((1R,2S,5S)-2-amino-5-(dimethyl carbamoyl) cyclohexyl) carbamate
365998-36-3
|
1KG Ton | 99%+ | 2 tons/month | ZHUHAI HRD PHARMACEUTICAL CO., LTD. |
-
![(5H-Pyrrolo[3,4-d]thiazole-5-carboxylic acid,2-[[[(1R,2S,5S)-2-[[(5-chloro-1H-indol-2-yl)carbonyl]aMino]-5-[(diMethylaMino)carbonyl]cyclohexyl]aMino]carbonyl]-4,6-dihydro-,1,1-diMethylethyl ester pictures](/ProductImageEN1/2025-04/Small/1b0a449d-b67c-413d-ac71-8f2f8e38e023.gif)
- (5H-Pyrrolo[3,4-d]thiazole-5-carboxylic acid,2-[[[(1R,2S,5S)-2-[[(5-chloro-1H-indol-2-yl)carbonyl]aMino]-5-[(diMethylaMino)carbonyl]cyclohexyl]aMino]carbonyl]-4,6-dihydro-,1,1-diMethylethyl ester
365998-36-3
- 0.99
- RongNa Biotechnology Co.,Ltd
-

- tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate
365998-36-3
- 99.99%
- Anhuyan (Hainan) Biotechnology Co., LTD
-

- Tert-Butyl ((1R,2S,5S)-2-amino-5-(dimethyl carbamoyl) cyclohexyl) carbamate
365998-36-3
- $0.00
- 99%+
- ZHUHAI HRD PHARMACEUTICAL CO., LTD.
365998-36-3 (tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate) Related Search:
1of4





